A New Conditional Transcription Factor for Use in Toxoplasma Gondii

Area of Science:

• Parasitology
• Molecular Biology
• Genetics

Background:

• Toxoplasma gondii is an intracellular parasite.
• Previous gene transcription control in Toxoplasma used a tetracycline-controlled tet-off system.
• The tet-off system had limitations including modest signal-to-noise ratios and significant leakiness.

Purpose of the Study:

• To develop a new, reversible, and robust Conditional Transcription Factor (CTF) for gene regulation in Toxoplasma gondii.
• To overcome the limitations of existing gene control systems in this parasite.
• To achieve precise control over gene transcription with minimal background expression.

Main Methods:

• Development of a novel Conditional Transcription Factor (CTF) regulated by rapamycin.
• Stable transfection of tachyzoites with the CTF and a fluorescent reporter gene (EYFP).
• Evaluation of gene expression levels and signal-to-noise ratios in the presence and absence of rapamycin.

Main Results:

• The CTF functions in a drug-off manner, exhibiting near-zero leakiness in the presence of rapamycin.
• In the absence of rapamycin, 84% of tachyzoites expressed EYFP, comparable to constitutive controls.
• Achieved an impressive signal-to-noise ratio (SNR) averaging 1489, functioning like an "on/off" switch.

Conclusions:

• The rapamycin-controlled CTF provides a significant improvement for conditional gene expression in Toxoplasma gondii.
• The system offers high fidelity and robustness, overcoming limitations of prior methods.
• The modular design facilitates adaptation for diverse genes and other apicomplexan organisms.